Global Celiac Disease Drug Market Research Report 2023

The global Celiac Disease Drug market was valued at US$ 597.3 million in 2022 and is anticipated to reach US$ 1603.3 million by 2029, witnessing a CAGR of 14.9% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Celiac Disease Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Celiac Disease Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Celiac Disease Drug include F. Hoffmann-La Roche, Johnson & Johnson, Merck, Pfizer, ADMA Biologics, Amgen, Anthera Pharmaceuticals, Bayer and Biogen, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Celiac Disease Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Celiac Disease Drug.

The Celiac Disease Drug market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Celiac Disease Drug market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Celiac Disease Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

1.1 Product Overview and Scope of Celiac Disease Drug

1.2 Celiac Disease Drug Segment by Type

1.2.1 Global Celiac Disease Drug Market Value Comparison by Type (2023-2029)

1.2.2 Distension

1.2.3 Diarrhea

1.2.4 Anorexia

1.2.5 Others

1.3 Celiac Disease Drug Segment by Application

1.3.1 Global Celiac Disease Drug Market Value by Application: (2023-2029)

1.3.2 First Line of Treatment

1.3.3 Second Line of Treatment

1.4 Global Celiac Disease Drug Market Size Estimates and Forecasts

1.4.1 Global Celiac Disease Drug Revenue 2018-2029

1.4.2 Global Celiac Disease Drug Sales 2018-2029

1.4.3 Global Celiac Disease Drug Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Celiac Disease Drug Sales Market Share by Manufacturers (2018-2023)

2.2 Global Celiac Disease Drug Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Celiac Disease Drug Average Price by Manufacturers (2018-2023)

2.4 Global Celiac Disease Drug Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Celiac Disease Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Celiac Disease Drug, Product Type & Application

2.7 Celiac Disease Drug Market Competitive Situation and Trends

2.7.1 Celiac Disease Drug Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Celiac Disease Drug Players Market Share by Revenue

2.7.3 Global Celiac Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Celiac Disease Drug Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Celiac Disease Drug Global Celiac Disease Drug Sales by Region: 2018-2029

3.2.1 Global Celiac Disease Drug Sales by Region: 2018-2023

3.2.2 Global Celiac Disease Drug Sales by Region: 2024-2029

3.3 Global Celiac Disease Drug Global Celiac Disease Drug Revenue by Region: 2018-2029

3.3.1 Global Celiac Disease Drug Revenue by Region: 2018-2023

3.3.2 Global Celiac Disease Drug Revenue by Region: 2024-2029

3.4 North America Celiac Disease Drug Market Facts & Figures by Country

3.4.1 North America Celiac Disease Drug Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Celiac Disease Drug Sales by Country (2018-2029)

3.4.3 North America Celiac Disease Drug Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Celiac Disease Drug Market Facts & Figures by Country

3.5.1 Europe Celiac Disease Drug Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Celiac Disease Drug Sales by Country (2018-2029)

3.5.3 Europe Celiac Disease Drug Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Celiac Disease Drug Market Facts & Figures by Country

3.6.1 Asia Pacific Celiac Disease Drug Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Celiac Disease Drug Sales by Country (2018-2029)

3.6.3 Asia Pacific Celiac Disease Drug Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Celiac Disease Drug Market Facts & Figures by Country

3.7.1 Latin America Celiac Disease Drug Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Celiac Disease Drug Sales by Country (2018-2029)

3.7.3 Latin America Celiac Disease Drug Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Celiac Disease Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Celiac Disease Drug Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Celiac Disease Drug Sales by Country (2018-2029)

3.8.3 Middle East and Africa Celiac Disease Drug Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Celiac Disease Drug Sales by Type (2018-2029)

4.1.1 Global Celiac Disease Drug Sales by Type (2018-2023)

4.1.2 Global Celiac Disease Drug Sales by Type (2024-2029)

4.1.3 Global Celiac Disease Drug Sales Market Share by Type (2018-2029)

4.2 Global Celiac Disease Drug Revenue by Type (2018-2029)

4.2.1 Global Celiac Disease Drug Revenue by Type (2018-2023)

4.2.2 Global Celiac Disease Drug Revenue by Type (2024-2029)

4.2.3 Global Celiac Disease Drug Revenue Market Share by Type (2018-2029)

4.3 Global Celiac Disease Drug Price by Type (2018-2029)

5.1 Global Celiac Disease Drug Sales by Application (2018-2029)

5.1.1 Global Celiac Disease Drug Sales by Application (2018-2023)

5.1.2 Global Celiac Disease Drug Sales by Application (2024-2029)

5.1.3 Global Celiac Disease Drug Sales Market Share by Application (2018-2029)

5.2 Global Celiac Disease Drug Revenue by Application (2018-2029)

5.2.1 Global Celiac Disease Drug Revenue by Application (2018-2023)

5.2.2 Global Celiac Disease Drug Revenue by Application (2024-2029)

5.2.3 Global Celiac Disease Drug Revenue Market Share by Application (2018-2029)

5.3 Global Celiac Disease Drug Price by Application (2018-2029)

6.1 F. Hoffmann-La Roche

6.1.1 F. Hoffmann-La Roche Corporation Information

6.1.2 F. Hoffmann-La Roche Description and Business Overview

6.1.3 F. Hoffmann-La Roche Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2023)

6.1.4 F. Hoffmann-La Roche Celiac Disease Drug Product Portfolio

6.1.5 F. Hoffmann-La Roche Recent Developments/Updates

6.2 Johnson & Johnson

6.2.1 Johnson & Johnson Corporation Information

6.2.2 Johnson & Johnson Description and Business Overview

6.2.3 Johnson & Johnson Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Johnson & Johnson Celiac Disease Drug Product Portfolio

6.2.5 Johnson & Johnson Recent Developments/Updates

6.3 Merck

6.3.1 Merck Corporation Information

6.3.2 Merck Description and Business Overview

6.3.3 Merck Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Merck Celiac Disease Drug Product Portfolio

6.3.5 Merck Recent Developments/Updates

6.4 Pfizer

6.4.1 Pfizer Corporation Information

6.4.2 Pfizer Description and Business Overview

6.4.3 Pfizer Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Pfizer Celiac Disease Drug Product Portfolio

6.4.5 Pfizer Recent Developments/Updates

6.5 ADMA Biologics

6.5.1 ADMA Biologics Corporation Information

6.5.2 ADMA Biologics Description and Business Overview

6.5.3 ADMA Biologics Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2023)

6.5.4 ADMA Biologics Celiac Disease Drug Product Portfolio

6.5.5 ADMA Biologics Recent Developments/Updates

6.6 Amgen

6.6.1 Amgen Corporation Information

6.6.2 Amgen Description and Business Overview

6.6.3 Amgen Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Amgen Celiac Disease Drug Product Portfolio

6.6.5 Amgen Recent Developments/Updates

6.7 Anthera Pharmaceuticals

6.6.1 Anthera Pharmaceuticals Corporation Information

6.6.2 Anthera Pharmaceuticals Description and Business Overview

6.6.3 Anthera Pharmaceuticals Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Anthera Pharmaceuticals Celiac Disease Drug Product Portfolio

6.7.5 Anthera Pharmaceuticals Recent Developments/Updates

6.8 Bayer

6.8.1 Bayer Corporation Information

6.8.2 Bayer Description and Business Overview

6.8.3 Bayer Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Bayer Celiac Disease Drug Product Portfolio

6.8.5 Bayer Recent Developments/Updates

6.9 Biogen

6.9.1 Biogen Corporation Information

6.9.2 Biogen Description and Business Overview

6.9.3 Biogen Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2023)

6.9.4 Biogen Celiac Disease Drug Product Portfolio

6.9.5 Biogen Recent Developments/Updates

6.10 BioLineRx

6.10.1 BioLineRx Corporation Information

6.10.2 BioLineRx Description and Business Overview

6.10.3 BioLineRx Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2023)

6.10.4 BioLineRx Celiac Disease Drug Product Portfolio

6.10.5 BioLineRx Recent Developments/Updates

6.11 Biotest

6.11.1 Biotest Corporation Information

6.11.2 Biotest Celiac Disease Drug Description and Business Overview

6.11.3 Biotest Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2023)

6.11.4 Biotest Celiac Disease Drug Product Portfolio

6.11.5 Biotest Recent Developments/Updates

6.12 Bristol-Myers Squibb

6.12.1 Bristol-Myers Squibb Corporation Information

6.12.2 Bristol-Myers Squibb Celiac Disease Drug Description and Business Overview

6.12.3 Bristol-Myers Squibb Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2023)

6.12.4 Bristol-Myers Squibb Celiac Disease Drug Product Portfolio

6.12.5 Bristol-Myers Squibb Recent Developments/Updates

6.13 Celgene

6.13.1 Celgene Corporation Information

6.13.2 Celgene Celiac Disease Drug Description and Business Overview

6.13.3 Celgene Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2023)

6.13.4 Celgene Celiac Disease Drug Product Portfolio

6.13.5 Celgene Recent Developments/Updates

6.14 Takeda Pharmaceutical

6.14.1 Takeda Pharmaceutical Corporation Information

6.14.2 Takeda Pharmaceutical Celiac Disease Drug Description and Business Overview

6.14.3 Takeda Pharmaceutical Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2023)

6.14.4 Takeda Pharmaceutical Celiac Disease Drug Product Portfolio

6.14.5 Takeda Pharmaceutical Recent Developments/Updates

6.15 Novartis

6.15.1 Novartis Corporation Information

6.15.2 Novartis Celiac Disease Drug Description and Business Overview

6.15.3 Novartis Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2023)

6.15.4 Novartis Celiac Disease Drug Product Portfolio

6.15.5 Novartis Recent Developments/Updates

6.16 LFB Group

6.16.1 LFB Group Corporation Information

6.16.2 LFB Group Celiac Disease Drug Description and Business Overview

6.16.3 LFB Group Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2023)

6.16.4 LFB Group Celiac Disease Drug Product Portfolio

6.16.5 LFB Group Recent Developments/Updates

6.17 Kedrion Biopharma

6.17.1 Kedrion Biopharma Corporation Information

6.17.2 Kedrion Biopharma Celiac Disease Drug Description and Business Overview

6.17.3 Kedrion Biopharma Celiac Disease Drug Sales, Revenue and Gross Margin (2018-2023)

6.17.4 Kedrion Biopharma Celiac Disease Drug Product Portfolio

6.17.5 Kedrion Biopharma Recent Developments/Updates

7.1 Celiac Disease Drug Industry Chain Analysis

7.2 Celiac Disease Drug Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Celiac Disease Drug Production Mode & Process

7.4 Celiac Disease Drug Sales and Marketing

7.4.1 Celiac Disease Drug Sales Channels

7.4.2 Celiac Disease Drug Distributors

7.5 Celiac Disease Drug Customers

8.1 Celiac Disease Drug Industry Trends

8.2 Celiac Disease Drug Market Drivers

8.3 Celiac Disease Drug Market Challenges

8.4 Celiac Disease Drug Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Celiac Disease Drug Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Celiac Disease Drug Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Celiac Disease Drug Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Celiac Disease Drug Sales (K Pcs) of Key Manufacturers (2018-2023)

    Table 5. Global Celiac Disease Drug Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Celiac Disease Drug Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Celiac Disease Drug Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Celiac Disease Drug Average Price (USD/Pcs) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Celiac Disease Drug, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Celiac Disease Drug, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Celiac Disease Drug, Product Type & Application

    Table 12. Global Key Manufacturers of Celiac Disease Drug, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Celiac Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celiac Disease Drug as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Celiac Disease Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Celiac Disease Drug Sales by Region (2018-2023) & (K Pcs)

    Table 18. Global Celiac Disease Drug Sales Market Share by Region (2018-2023)

    Table 19. Global Celiac Disease Drug Sales by Region (2024-2029) & (K Pcs)

    Table 20. Global Celiac Disease Drug Sales Market Share by Region (2024-2029)

    Table 21. Global Celiac Disease Drug Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Celiac Disease Drug Revenue Market Share by Region (2018-2023)

    Table 23. Global Celiac Disease Drug Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Celiac Disease Drug Revenue Market Share by Region (2024-2029)

    Table 25. North America Celiac Disease Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Celiac Disease Drug Sales by Country (2018-2023) & (K Pcs)

    Table 27. North America Celiac Disease Drug Sales by Country (2024-2029) & (K Pcs)

    Table 28. North America Celiac Disease Drug Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Celiac Disease Drug Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Celiac Disease Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Celiac Disease Drug Sales by Country (2018-2023) & (K Pcs)

    Table 32. Europe Celiac Disease Drug Sales by Country (2024-2029) & (K Pcs)

    Table 33. Europe Celiac Disease Drug Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Celiac Disease Drug Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Celiac Disease Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Celiac Disease Drug Sales by Region (2018-2023) & (K Pcs)

    Table 37. Asia Pacific Celiac Disease Drug Sales by Region (2024-2029) & (K Pcs)

    Table 38. Asia Pacific Celiac Disease Drug Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Celiac Disease Drug Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Celiac Disease Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Celiac Disease Drug Sales by Country (2018-2023) & (K Pcs)

    Table 42. Latin America Celiac Disease Drug Sales by Country (2024-2029) & (K Pcs)

    Table 43. Latin America Celiac Disease Drug Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Celiac Disease Drug Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Celiac Disease Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Celiac Disease Drug Sales by Country (2018-2023) & (K Pcs)

    Table 47. Middle East & Africa Celiac Disease Drug Sales by Country (2024-2029) & (K Pcs)

    Table 48. Middle East & Africa Celiac Disease Drug Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Celiac Disease Drug Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Celiac Disease Drug Sales (K Pcs) by Type (2018-2023)

    Table 51. Global Celiac Disease Drug Sales (K Pcs) by Type (2024-2029)

    Table 52. Global Celiac Disease Drug Sales Market Share by Type (2018-2023)

    Table 53. Global Celiac Disease Drug Sales Market Share by Type (2024-2029)

    Table 54. Global Celiac Disease Drug Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Celiac Disease Drug Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Celiac Disease Drug Revenue Market Share by Type (2018-2023)

    Table 57. Global Celiac Disease Drug Revenue Market Share by Type (2024-2029)

    Table 58. Global Celiac Disease Drug Price (USD/Pcs) by Type (2018-2023)

    Table 59. Global Celiac Disease Drug Price (USD/Pcs) by Type (2024-2029)

    Table 60. Global Celiac Disease Drug Sales (K Pcs) by Application (2018-2023)

    Table 61. Global Celiac Disease Drug Sales (K Pcs) by Application (2024-2029)

    Table 62. Global Celiac Disease Drug Sales Market Share by Application (2018-2023)

    Table 63. Global Celiac Disease Drug Sales Market Share by Application (2024-2029)

    Table 64. Global Celiac Disease Drug Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Celiac Disease Drug Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Celiac Disease Drug Revenue Market Share by Application (2018-2023)

    Table 67. Global Celiac Disease Drug Revenue Market Share by Application (2024-2029)

    Table 68. Global Celiac Disease Drug Price (USD/Pcs) by Application (2018-2023)

    Table 69. Global Celiac Disease Drug Price (USD/Pcs) by Application (2024-2029)

    Table 70. F. Hoffmann-La Roche Corporation Information

    Table 71. F. Hoffmann-La Roche Description and Business Overview

    Table 72. F. Hoffmann-La Roche Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 73. F. Hoffmann-La Roche Celiac Disease Drug Product

    Table 74. F. Hoffmann-La Roche Recent Developments/Updates

    Table 75. Johnson & Johnson Corporation Information

    Table 76. Johnson & Johnson Description and Business Overview

    Table 77. Johnson & Johnson Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 78. Johnson & Johnson Celiac Disease Drug Product

    Table 79. Johnson & Johnson Recent Developments/Updates

    Table 80. Merck Corporation Information

    Table 81. Merck Description and Business Overview

    Table 82. Merck Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 83. Merck Celiac Disease Drug Product

    Table 84. Merck Recent Developments/Updates

    Table 85. Pfizer Corporation Information

    Table 86. Pfizer Description and Business Overview

    Table 87. Pfizer Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 88. Pfizer Celiac Disease Drug Product

    Table 89. Pfizer Recent Developments/Updates

    Table 90. ADMA Biologics Corporation Information

    Table 91. ADMA Biologics Description and Business Overview

    Table 92. ADMA Biologics Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 93. ADMA Biologics Celiac Disease Drug Product

    Table 94. ADMA Biologics Recent Developments/Updates

    Table 95. Amgen Corporation Information

    Table 96. Amgen Description and Business Overview

    Table 97. Amgen Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 98. Amgen Celiac Disease Drug Product

    Table 99. Amgen Recent Developments/Updates

    Table 100. Anthera Pharmaceuticals Corporation Information

    Table 101. Anthera Pharmaceuticals Description and Business Overview

    Table 102. Anthera Pharmaceuticals Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 103. Anthera Pharmaceuticals Celiac Disease Drug Product

    Table 104. Anthera Pharmaceuticals Recent Developments/Updates

    Table 105. Bayer Corporation Information

    Table 106. Bayer Description and Business Overview

    Table 107. Bayer Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 108. Bayer Celiac Disease Drug Product

    Table 109. Bayer Recent Developments/Updates

    Table 110. Biogen Corporation Information

    Table 111. Biogen Description and Business Overview

    Table 112. Biogen Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 113. Biogen Celiac Disease Drug Product

    Table 114. Biogen Recent Developments/Updates

    Table 115. BioLineRx Corporation Information

    Table 116. BioLineRx Description and Business Overview

    Table 117. BioLineRx Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 118. BioLineRx Celiac Disease Drug Product

    Table 119. BioLineRx Recent Developments/Updates

    Table 120. Biotest Corporation Information

    Table 121. Biotest Description and Business Overview

    Table 122. Biotest Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 123. Biotest Celiac Disease Drug Product

    Table 124. Biotest Recent Developments/Updates

    Table 125. Bristol-Myers Squibb Corporation Information

    Table 126. Bristol-Myers Squibb Description and Business Overview

    Table 127. Bristol-Myers Squibb Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 128. Bristol-Myers Squibb Celiac Disease Drug Product

    Table 129. Bristol-Myers Squibb Recent Developments/Updates

    Table 130. Celgene Corporation Information

    Table 131. Celgene Description and Business Overview

    Table 132. Celgene Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 133. Celgene Celiac Disease Drug Product

    Table 134. Celgene Recent Developments/Updates

    Table 135. Takeda Pharmaceutical Corporation Information

    Table 136. Takeda Pharmaceutical Description and Business Overview

    Table 137. Takeda Pharmaceutical Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 138. Takeda Pharmaceutical Celiac Disease Drug Product

    Table 139. Takeda Pharmaceutical Recent Developments/Updates

    Table 140. Novartis Corporation Information

    Table 141. Novartis Description and Business Overview

    Table 142. Novartis Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 143. Novartis Celiac Disease Drug Product

    Table 144. Novartis Recent Developments/Updates

    Table 145. LFB Group Corporation Information

    Table 146. LFB Group Description and Business Overview

    Table 147. LFB Group Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 148. LFB Group Celiac Disease Drug Product

    Table 149. LFB Group Recent Developments/Updates

    Table 150. Kedrion Biopharma Corporation Information

    Table 151. Kedrion Biopharma Description and Business Overview

    Table 152. Kedrion Biopharma Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 153. Kedrion Biopharma Celiac Disease Drug Product

    Table 154. Kedrion Biopharma Recent Developments/Updates

    Table 155. Key Raw Materials Lists

    Table 156. Raw Materials Key Suppliers Lists

    Table 157. Celiac Disease Drug Distributors List

    Table 158. Celiac Disease Drug Customers List

    Table 159. Celiac Disease Drug Market Trends

    Table 160. Celiac Disease Drug Market Drivers

    Table 161. Celiac Disease Drug Market Challenges

    Table 162. Celiac Disease Drug Market Restraints

    Table 163. Research Programs/Design for This Report

    Table 164. Key Data Information from Secondary Sources

    Table 165. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Celiac Disease Drug

    Figure 2. Global Celiac Disease Drug Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Celiac Disease Drug Market Share by Type in 2022 & 2029

    Figure 4. Distension Product Picture

    Figure 5. Diarrhea Product Picture

    Figure 6. Anorexia Product Picture

    Figure 7. Others Product Picture

    Figure 8. Global Celiac Disease Drug Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 9. Global Celiac Disease Drug Market Share by Application in 2022 & 2029

    Figure 10. First Line of Treatment

    Figure 11. Second Line of Treatment

    Figure 12. Global Celiac Disease Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Celiac Disease Drug Market Size (2018-2029) & (US$ Million)

    Figure 14. Global Celiac Disease Drug Sales (2018-2029) & (K Pcs)

    Figure 15. Global Celiac Disease Drug Average Price (USD/Pcs) & (2018-2029)

    Figure 16. Celiac Disease Drug Report Years Considered

    Figure 17. Celiac Disease Drug Sales Share by Manufacturers in 2022

    Figure 18. Global Celiac Disease Drug Revenue Share by Manufacturers in 2022

    Figure 19. The Global 5 and 10 Largest Celiac Disease Drug Players: Market Share by Revenue in 2022

    Figure 20. Celiac Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 21. Global Celiac Disease Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 22. North America Celiac Disease Drug Sales Market Share by Country (2018-2029)

    Figure 23. North America Celiac Disease Drug Revenue Market Share by Country (2018-2029)

    Figure 24. U.S. Celiac Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 25. Canada Celiac Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 26. Europe Celiac Disease Drug Sales Market Share by Country (2018-2029)

    Figure 27. Europe Celiac Disease Drug Revenue Market Share by Country (2018-2029)

    Figure 28. Germany Celiac Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. France Celiac Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. U.K. Celiac Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Italy Celiac Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Russia Celiac Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. Asia Pacific Celiac Disease Drug Sales Market Share by Region (2018-2029)

    Figure 34. Asia Pacific Celiac Disease Drug Revenue Market Share by Region (2018-2029)

    Figure 35. China Celiac Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. Japan Celiac Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. South Korea Celiac Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. India Celiac Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. Australia Celiac Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Taiwan Celiac Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Indonesia Celiac Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Thailand Celiac Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Malaysia Celiac Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Philippines Celiac Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Latin America Celiac Disease Drug Sales Market Share by Country (2018-2029)

    Figure 46. Latin America Celiac Disease Drug Revenue Market Share by Country (2018-2029)

    Figure 47. Mexico Celiac Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Brazil Celiac Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Argentina Celiac Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 50. Middle East & Africa Celiac Disease Drug Sales Market Share by Country (2018-2029)

    Figure 51. Middle East & Africa Celiac Disease Drug Revenue Market Share by Country (2018-2029)

    Figure 52. Turkey Celiac Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Saudi Arabia Celiac Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. UAE Celiac Disease Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 55. Global Sales Market Share of Celiac Disease Drug by Type (2018-2029)

    Figure 56. Global Revenue Market Share of Celiac Disease Drug by Type (2018-2029)

    Figure 57. Global Celiac Disease Drug Price (USD/Pcs) by Type (2018-2029)

    Figure 58. Global Sales Market Share of Celiac Disease Drug by Application (2018-2029)

    Figure 59. Global Revenue Market Share of Celiac Disease Drug by Application (2018-2029)

    Figure 60. Global Celiac Disease Drug Price (USD/Pcs) by Application (2018-2029)

    Figure 61. Celiac Disease Drug Value Chain

    Figure 62. Celiac Disease Drug Production Process

    Figure 63. Channels of Distribution (Direct Vs Distribution)

    Figure 64. Distributors Profiles

    Figure 65. Bottom-up and Top-down Approaches for This Report

    Figure 66. Data Triangulation

    Figure 67. Key Executives Interviewed